Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02390908 · ClinicalTrials.gov registry record · NA
Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings
A NA study of HIV and Medication Adherence, sponsored by Hunter College of City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
- 1
- Study location
NCT02390908 is a NA study of HIV and Medication Adherence that has completed, run by Hunter College of City University of New York. The registered enrollment target is 174 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02390908, a NA study of HIV and Medication Adherence, has completed, sponsored by Hunter College of City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
- 1
- Study location
Study Summary
Alcohol use is increasingly recognized as a key factor in morbidity and mortality among HIV-positive individuals and represents an important public health concern, given its associations with medication non-adherence, increases in viral load, poor immunologic outcomes (lower cluster of differentiation 4, or CD4, counts), drug resistance, lower health care utilization, comorbidities (HIV/viral hepatitis coinfection), and poor health outcomes overall. Adherence to HIV medications has a double public health benefit, both in terms of slowing disease progression and improving health outcomes among HIV-positive individuals and in helping to curb the sexual transmission of HIV. The objective of this study is to implement a multisite comparative effectiveness trial in real-world clinical settings with three intensities of treatment to test the clinical and cost effectiveness of an efficacious, theory-based behavioral intervention (PLUS) in improving adherence to antiretroviral therapy (ART) and alcohol-related outcomes among HIV-positive individuals who drink alcohol at harmful or hazardous levels. The study is being conducted in collaboration between the Center for HIV Educational Studies and Training (CHEST) at Hunter College at the City University of New York (CUNY) and the Spencer Cox Center for Health at the Institute for Advanced Medicine, Mount Sinai Health System.
Conditions Studied
Interventions
- BEHAVIORAL Immediate PLUS intervention
- BEHAVIORAL Wait-list PLUS intervention
Study Locations (1)
New York
- Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2013-08-01 |
| Est. Completion | 2018-05-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02390908
The ClinicalTrials.gov registry entry for NCT02390908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (60% lower). The listed sponsor is Hunter College of City University of New York, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Immediate PLUS intervention is the first listed.
NCT02390908 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02390908 about?
NCT02390908 is a clinical study titled "Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings". Alcohol use is increasingly recognized as a key factor in morbidity and mortality among HIV-positive individuals and represents an important public health concern, given its associations with medication non-adherence, increases in viral load, poor immunologic outcomes (lower cluster of differentiati...
What is the current status of trial NCT02390908?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2013-08-01. Estimated completion is 2018-05-08.
What conditions does trial NCT02390908 study?
This clinical trial studies the following conditions: HIV, Medication Adherence, Alcohol Use.
What interventions are being tested in trial NCT02390908?
The interventions under investigation include: Immediate PLUS intervention (BEHAVIORAL), Wait-list PLUS intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02390908?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02390908 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.